Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis
Hongxiang Wei,1,* Fei Chen,1,* Jinyuan Chen,2,* Huangfeng Lin,1 Shenglin Wang,1 Yunqing Wang,1 Chaoyang Wu,1 Jianhua Lin,1 Guangxian Zhong1 1Department of Orthopaedics, Fujian Institute of Orthopaedics, the First Affiliated Hospital of Fujian Medical University, Fuzhou, 35000...
Main Authors: | Wei H, Chen F, Chen J, Lin H, Wang S, Wang Y, Wu C, Lin J, Zhong G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-08-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/mesenchymal-stem-cell-derived-exosomes-as-nanodrug-carrier-of-doxorubi-peer-reviewed-fulltext-article-IJN |
Similar Items
-
A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro
by: Wei H, et al.
Published: (2019-11-01) -
Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo
by: Jinkui Wang, et al.
Published: (2022-12-01) -
Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
by: Hadeel Halalsheh, et al.
Published: (2023-07-01) -
Chitosan-Boric Acid Scaffolds for Doxorubicin Delivery in the Osteosarcoma Treatment
by: Luka Dornjak, et al.
Published: (2022-11-01) -
Exosomes and osteosarcoma drug resistance
by: Huichao Fu, et al.
Published: (2023-03-01)